Paper37153003
Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.
Fang X and 3 others. Front Genet, 2023. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer. Papers, record 37153003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37153003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of non-coding RNA related prognosis biomarkers based on ceRNA network in thyroid cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19016336 | International patterns and trends in thyroid cancer incidence, 1973-2002. | Cancer Causes Control | 2009 | https://conductscience.org/library/papers/19016336 | PubMed |
| 2 | 26007293 | MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. | Clin Exp Metastasis | 2015 | https://conductscience.org/library/papers/26007293 | PubMed |
| 3 | 29423063 | LncRNA Gas5 acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p in papillary thyroid carcinoma. | Oncotarget | 2018 | https://conductscience.org/library/papers/29423063 | PubMed |
| 4 | 26358722 | ceRNA in cancer: possible functions and clinical implications. | J Med Genet | 2015 | https://conductscience.org/library/papers/26358722 | PubMed |
| 5 | 29107050 | MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma. | Exp Mol Pathol | 2017 | https://conductscience.org/library/papers/29107050 | PubMed |
| 6 | 29474928 | LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. | Int J Biochem Cell Biol | 2018 | https://conductscience.org/library/papers/29474928 | PubMed |
| 7 | 23498938 | Long noncoding RNAs: cellular address codes in development and disease. | Cell | 2013 | https://conductscience.org/library/papers/23498938 | PubMed |
| 8 | 9874472 | A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. | Cancer | 1998 | https://conductscience.org/library/papers/9874472 | PubMed |
| 9 | 27470543 | MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27470543 | PubMed |
| 10 | 34811354 | LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34811354 | PubMed |
| 11 | 25284703 | Thyroid cancer mortality and incidence: a global overview. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25284703 | PubMed |
| 12 | 27460006 | 8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth. | Endocrine | 2017 | https://conductscience.org/library/papers/27460006 | PubMed |
| 13 | 28617552 | Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28617552 | PubMed |
| 14 | 25487826 | Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer. | Cancer Med | 2015 | https://conductscience.org/library/papers/25487826 | PubMed |
| 15 | 19240234 | Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. | Cancer Epidemiol Biomarkers Prev | 2009 | https://conductscience.org/library/papers/19240234 | PubMed |
| 16 | 23622238 | The long and short of microRNA. | Cell | 2013 | https://conductscience.org/library/papers/23622238 | PubMed |
| 17 | 30938104 | Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling. | Cancer Med | 2019 | https://conductscience.org/library/papers/30938104 | PubMed |
| 18 | 26755660 | Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. | Oncotarget | 2016 | https://conductscience.org/library/papers/26755660 | PubMed |
| 19 | 21874046 | MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. | Oncogene | 2012 | https://conductscience.org/library/papers/21874046 | PubMed |
| 20 | 29720189 | LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29720189 | PubMed |
Genes37
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37153003
GET https://conductscience.org/api/papers/v1/37153003/references?page=2